Interference with gene expression induces rapid apoptosis in p53-null T lymphoma cells

Cell Death and Differentiation

Volumn 6, Issue 12, 1999, Pages 1216-1221

  Ofir, R ^a   Zhang, L C ^a   Adams, J M ^a  

^a NONE

Author keywords

Apoptosis; Cycloheximide; Cytotoxic therapy; p53

Indexed keywords

CALCINEURIN; CASPASE INHIBITOR; CYCLOHEXIMIDE; DACTINOMYCIN; DNA FRAGMENT; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN P53; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; GENE REPRESSION; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; T CELL LYMPHOMA;

ANIMALIA;

EID: 0033381212     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400612     Document Type: Article

References (42)

1. Thornberry NA and Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1316
2. Weil M, Jacobson MD, Coles HSR, Davies TJ, Gardner RL, Raff KD and Raff MC (1996) Constitutive expression of the machinery for programmed cell death. J. Cell Biol. 133: 1053-1059
3. Adams JM and Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326
4. Cohen JJ (1992) Glucocorticoid-induced apoptosis in the thymus. Semin. Immunol. 4: 363-369
5. Osborne BA, Smith SW, Liu ZG, McLaughlin KA, Grimm L and Schwartz LM (1994) Identification of genes induced during apoptosis in T lymphocytes. Immunol. Rev. 142: 301-320
6. Martin SJ, Lennon SV, Bonham AM and Cotter TG (1990) Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol. 145: 1859-1867
7. Kochi SK and Collier RJ (1993) DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. Exp. Cell Res. 208: 296-302
8. Vaux DL and Weissman IL (1993) Neither macromolecular synthesis nor myc is required for cell death via the mechanism that can be controlled by Bcl-2. Mol. Cell. Biol. 13: 7000-7005
9. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331
10. Mowat MR (1998) p53 in tumor progression: life, death, and everything. Adv. Cancer Res. 74: 25-48
11. Miyashita T and Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299
12. Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389: 300-305
13. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
14. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852
15. Strasser A, Harris AW, Jacks T and Cory S (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79: 329-339
16. Minden A and Karin M (1997) Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta 1333: F85-F104
17. Ip YT and Davis RJ (1998) Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell Biol. 10: 205-219
18. Franke TF, Kaplan DR and Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88: 435-437
19. Franke TF and Cantley LC (1997) A bad kinase makes good. Nature 390: 116-117
20. 2+-activated cell death in mammalian cells. J. Cell Biol. 131: 735-743
21. Shibasaki F, Kondo E, Akagi T and McKeon F (1997) Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 386: 728-731
22. Ashkenazi A and Dixit VM (1998) Death receptors: signaling and modulation. Science 281: 1305-1308
23. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P and Wallach D (1998) Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9: 267-276
24. Guerini D (1997) Calcineurin: not just a simple protein phosphatase. Biochem. Biophys. Res. Commun. 235: 271-275
25. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT and Nicholson DW (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 272: 17907-17911
26. Bokoch GM (1998) Caspase-mediated activation of PAK2 during apoptosis: proteolytic kinase activation as a general mechanism of apoptotic signal transduction? Cell Death Differ. 5: 637-645
27. Guo YL, Kang B and Williamson JR (1998) Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-α in rat mesangial cells. J. Biol. Chem. 273: 10362-10366
28. Franklin CC, Srikanth S and Kraft AS (1998) Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis. Proc. Natl. Acad. Sci. USA 95: 3014-3019
29. del Peso L, González-Garcia M, Page C, Herrera R and Nuñez G (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689
30. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the ce I-intrinsic death machinery. Cell 91: 231-241
31. L. Cell 87: 619-628
32. Sizemore N, Leung S and Stark GR (1999) Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-KB p65/RelA subunit. Mol. Cell. Biol. 19: 4798-4805
33. Tang D, Lahti JM, Grenet J and Kidd VJ (1999) Cycloheximide-induced T-cell death is mediated by a fas-associated death domain-dependent mechanism. J. Biol. Chem. 274: 7245-7252
34. Strasser A, Harris AW, Huang DCS, Krammer PH and Cory S (1995) Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14: 6136-6147
35. Newton K, Harris AW, Bath ML, Smith KGC and Strasser A (1998) A dominant interfering mutant of FADD/Mort1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17: 706-718
36. Evan G and Littlewood T (1998) A matter of life and cell death. Science 281: 1317-1321
37. Cory S, Vaux DL, Strasser A, Harris AW and Adams JM (1999) Insights from Bcl-2 and Myc: Malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res. 59: 1685s -1692s
38. Weller M (1998) Predicting response to cancer chemotherapy: the role of p53. Cell. Tissue Res. 292: 435-445
39. Petty RD, Cree IA, Sutherland LA, Hunter EM, Lane DP, Preece FE and Andreotti PE (1994) Expression of the p53 tumour suppressor gene product is a determinant of chemosensitivity. Biochem. Biophys. Res. Commun. 199: 264-270
40. Hawkins DS, Demers GW and Galloway DA (1996) Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res. 56: 892-898
41. Wang Y, Blandino G, Oren M and Givol D (1998) Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs. Oncogene 17: 1923-1930
42. Sellins KS and Cohen JJ (1987) Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139: 3199-3206